Rood, Ilse M <br/><br/>
Rituximab can induce remission of nephrotic syndrome in the absence of peripheral B-cells.  [electronic resource] 

 -  Nephrology (Carlton, Vic.)  Sep 2015 
 - 667-8 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1440-1797 
<br/><br/><label>Standard No.: </label>10.1111/nep.12492  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>B-Lymphocytes--drug effects<br/>Female<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Nephrotic Syndrome--diagnosis<br/>Remission Induction<br/>Rituximab--therapeutic use<br/>Treatment Outcome